R
Ronald T. Acton
Researcher at University of Alabama at Birmingham
Publications - 251
Citations - 8039
Ronald T. Acton is an academic researcher from University of Alabama at Birmingham. The author has contributed to research in topics: Hemochromatosis & Transferrin saturation. The author has an hindex of 42, co-authored 245 publications receiving 7660 citations. Previous affiliations of Ronald T. Acton include University of Alabama & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
Hemochromatosis and Iron-Overload Screening in a Racially Diverse Population
Paul C. Adams,David M. Reboussin,James C. Barton,Christine E. McLaren,John H. Eckfeldt,Gordon D. McLaren,Gordon D. McLaren,Fitzroy W. Dawkins,Ronald T. Acton,Emily L. Harris,Victor R. Gordeuk,Catherine Leiendecker-Foster,Mark Speechley,Beverly M. Snively,Joan Holup,Elizabeth J. Thomson,Phyliss Sholinsky +16 more
TL;DR: The C282y mutation is most common in whites, and most C282Y homozygotes have elevations in serum ferritin levels and transferrin saturation values in nonwhites.
Journal ArticleDOI
Plasma homocyst(e)ine, folate, and vitamin B-12 concentrations and risk for early-onset coronary artery disease.
N Pancharuniti,Charles A. Lewis,Howerde E. Sauberlich,L L Perkins,Rodney C.P. Go,J O Alvarez,M Macaluso,Ronald T. Acton,R B Copeland,A L Cousins +9 more
TL;DR: Reduction in plasma Hcy by interventions to increase plasma folate concentration may decrease CAD risk, and no difference in the geometric mean of vitamin B-12 concentration was found between patients and control subjects.
Journal ArticleDOI
The role of TNF and its receptors in Alzheimer’s disease
TL;DR: A significant asssociation of a TNFR2 exon 6 polymorphism with late-onset AD in families with no individuals possessing the APOE E4E4 genotype under a dominant model is found and no significant association of three polymorphisms in the TNFR1 gene to AD is found.
Journal ArticleDOI
Genetic Cancer Risk Assessment and Counseling: Recommendations of the National Society of Genetic Counselors
Angela Trepanier,Mary Ahrens,Wendy McKinnon,June A. Peters,Jill Stopfer,Sherry C. Grumet,Susan Manley,Julie O. Culver,Ronald T. Acton,Joy Larsen-Haidle,Lori Ann Correia,Robin L. Bennett,Barbara Pettersen,Terri Diamond Ferlita,Josephine Wagner Costalas,Katherine Hunt,Susan Donlon,Cécile Skrzynia,Carolyn Farrell,Faith Callif-Daley,Catherine Walsh Vockley +20 more
TL;DR: These cancer genetic counseling recommendations describe the medical, psychosocial, and ethical ramifications of identifying at-risk individuals through cancer risk assessment with or without genetic testing.
Journal ArticleDOI
Kidney Function Influences Warfarin Responsiveness and Hemorrhagic Complications
Nita A. Limdi,T. Mark Beasley,Melissa F. Baird,Joyce A. Goldstein,Gerald McGwin,Donna K. Arnett,Ronald T. Acton,Michael Allon +7 more
TL;DR: It is suggested that warfarin may need to be initiated at a lower dosage and monitored more closely in patients with moderate or severe CKD compared with the general population, because of the higher risk of major hemorrhage and poorer control of anticoagulation.